CN111150711B — 托法替布控释片、制备方法及其应用
Assigned to Shanghai Yunshengyan Neoplasm Technology Co ltd · Expires 2023-04-07 · 3y expired
What this patent protects
本发明公开了托法替布控释片、制备方法及其应用。本发明提供了一种托法替布控释片剂,其由含药片芯和控释包衣膜组成,其中,含药片芯包含托法替布原料药和辅料;控释包衣膜包含成膜材料、致孔剂和/或赋形剂。本发明的托法替布控释片,制备工艺不需要激光打孔,不需要特殊精密设备,简单易行,生产成本低周期短,且配制包衣液过程中不使用有机溶剂,避免对人体和环境造成不利影响,适合于工业化生产。
USPTO Abstract
本发明公开了托法替布控释片、制备方法及其应用。本发明提供了一种托法替布控释片剂,其由含药片芯和控释包衣膜组成,其中,含药片芯包含托法替布原料药和辅料;控释包衣膜包含成膜材料、致孔剂和/或赋形剂。本发明的托法替布控释片,制备工艺不需要激光打孔,不需要特殊精密设备,简单易行,生产成本低周期短,且配制包衣液过程中不使用有机溶剂,避免对人体和环境造成不利影响,适合于工业化生产。
Drugs covered by this patent
- Xeljanz (Tofacitinib Citrate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.